Delivery Order SPE2DB22D2005-SPE2DB25FJFA3

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D3505|SPE2DB25FT7F2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.68 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a completion date of January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,838.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Medroxyprogesterone 150 mg/mL, a medical product. It is a Firm Fixed Price contract with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,488.88, is a Firm Fixed Price Delivery Order for the supply of Medroxyprogesterone 150 mg/mL. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,294.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564674993 MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FNN77, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,627.84, and has an ultimate completion date of November 29, 2023. The contract is for the procurement of MEDROXYPROGESTERONE 150 MG/ML medical supplies, which are critical pharmaceuticals used in various healthcare applications....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a ceiling value of $1,511.15 and is a Firm Fixed Price Delivery Order, with a completion date of June 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.14 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through March 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,308.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564608211 - MEDROXYPROGESTERONE 150 MG/MLML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,177.04, is for the delivery of medroxyprogesterone 150 mg/ml, a medication used for various medical conditions. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 5, 2021. Amerisourcebergen Drug Corp is a subsidiary of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a firm fixed price, with a ceiling value of $3,016.81, and a performance period through July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJFA3
    Delivery Order

This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJFA3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,755.08 firm fixed-price delivery order is for the supply of 4566565091 - MEDROXYPROGESTERONE 150 MG/MLML, with a completion date of November 29, 2024. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military, veterans, and other federal beneficiaries.

Generated 5/20/25, 1:51 PM